Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C
Sign Up to like & getrecommendations! Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15287
Abstract: The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0.4 mg/ml. read more here.
Keywords: routine use; endophthalmitis blebitis; deep sclerectomy; use mitomycin ... See more keywords
Deep sclerectomy-trabeculectomy with mitomycin C in treating glaucoma: postoperative long-term results.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2022.12.09
Abstract: AIM To determine the long-term postoperative outcomes of deep sclerectomy-trabeculectomy (DST) with mitomycin C (MMC) in the treatment of glaucoma. METHODS Patients who underwent DST with MMC between 2010 and 2017 were included in this… read more here.
Keywords: long term; deep sclerectomy; iop; sclerectomy trabeculectomy ... See more keywords